Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/29/2007WO2007137040A2 7-(acryloyl) indole compositions and methods for making and using same
11/29/2007WO2007137029A1 Therapeutic fluoroethyl ureas
11/29/2007WO2007137008A2 Compounds for the treatment of metabolic disorders
11/29/2007WO2007137000A2 Combination cancer chemotherapy
11/29/2007WO2007136990A2 Prolyl hydroxylase inhibitors
11/29/2007WO2007136982A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
11/29/2007WO2007136940A2 Thiazolidinedione derivatives as pi3 kinase inhibitors
11/29/2007WO2007136921A2 Small molecule apoptosis promoters
11/29/2007WO2007136856A2 Heyl as a therapeutic target and a diagnostic marker for neoplasia and uses therefor
11/29/2007WO2007136830A2 Process for producing nanoparticles by spray drying
11/29/2007WO2007136817A2 Substituted aryl piperidinylalkynyladenosines as a2ar agonists
11/29/2007WO2007136810A2 Compositions and methods for enhancing mineral levels in animals with reduced environmental impact
11/29/2007WO2007136776A2 Pyrimidine low molecular weight ligands for modulating hormone receptors
11/29/2007WO2007136759A2 Method for the treatment and prevention of ocular disorders
11/29/2007WO2007136744A1 Crystal structure of a substrate complex of nampt/pbef/visfatin
11/29/2007WO2007136743A2 Dothiepin and methods of using the same to treat sleep disorders
11/29/2007WO2007136741A2 N-desmethyl-doxepin and methods of using the same to treat sleep disorders
11/29/2007WO2007136737A1 Methods and compositions for the treatment of viral infections
11/29/2007WO2007136719A2 Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof
11/29/2007WO2007136703A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/29/2007WO2007136696A2 Use of substituted azetidinone compounds with cetp inhibitors for the treatment of sitosterolemia
11/29/2007WO2007136692A2 Crystalline forms of 5-chloro-6- (2, 6-difluoro-4- [3- (methylamino) propoxy] phenyl)-n-((1s)-2, 2, 2,-trifluoro-1-methylethyl] [1,2,4] triazolo [1,5-a] pyrimidin-7-amine salts
11/29/2007WO2007136689A2 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
11/29/2007WO2007136680A2 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/29/2007WO2007136668A2 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
11/29/2007WO2007136653A2 Use of a rar antagonist or inverse agonist for the treatment of chemotherapy and/or radiation therapy side effects
11/29/2007WO2007136650A2 Method and compositions for treating hematological malignancies
11/29/2007WO2007136638A2 Prostaglandin transporter inhibitors
11/29/2007WO2007136636A1 Drug combinations to treat hyperproliferative disorders
11/29/2007WO2007136615A2 Combination cancer therapy
11/29/2007WO2007136607A2 Substituted esters as cannabinoid-1 receptor modulators
11/29/2007WO2007136605A2 Aryl-fused spirocyclic compounds
11/29/2007WO2007136603A2 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/29/2007WO2007136577A2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
11/29/2007WO2007136573A2 Antidiabetic bicyclic compounds
11/29/2007WO2007136571A1 Pro-drugs of tertiary alcohols
11/29/2007WO2007136570A2 5,6-fused pyrrolidine compounds useful as tachykinin receptor antagonists
11/29/2007WO2007136510A2 Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha
11/29/2007WO2007136465A2 Compositions and methods for fgf receptor kinases inhibitors
11/29/2007WO2007136428A2 Nutraceutical compositions from microalgae and related methods of production and administration
11/29/2007WO2007136326A2 ) t e text as een esta s e y t s ut o ty to rea as o ows: 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 3
11/29/2007WO2007136325A1 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 2
11/29/2007WO2007136324A1 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 1
11/29/2007WO2007136302A2 Active substances, pharmaceutical composition and a method for the production and use thereof
11/29/2007WO2007136300A2 Substituted indoles and a method for the production and use thereof
11/29/2007WO2007136151A1 Matrix tablets providing an extended release of metformin
11/29/2007WO2007136125A1 Compound having heterocyclic ring and use thereof
11/29/2007WO2007136116A2 C-phenyl glycitol compound for the treatment of diabetes
11/29/2007WO2007136107A1 Method of constructing gene transport support
11/29/2007WO2007136103A1 Antitumor agent for thyroid cancer
11/29/2007WO2007136085A1 Spiro tetracyclic compound
11/29/2007WO2007136084A1 Agent for ameliorating the condition of sick building syndrome
11/29/2007WO2007136068A1 Process for producing composition having high polyphenol content
11/29/2007WO2007135970A1 Heterocyclic type cinnamide derivative
11/29/2007WO2007135969A1 Urea type cinnamide derivative
11/29/2007WO2007135941A1 Method for production of acetic acid bacterium-type ceramide
11/29/2007WO2007135910A1 Polymer conjugate of podophyllotoxin
11/29/2007WO2007135766A1 Ointment for amelioration or treatment of oral tumor
11/29/2007WO2007135703A2 Patch for the treatment of the cellulite and localized adiposity
11/29/2007WO2007135592A1 Flavonoid dimers and methods of making and using such
11/29/2007WO2007135574A1 Use of parasympatholytic substances to enhance and accelerate stem cell differentiation, related method and compositions
11/29/2007WO2007135565A2 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof
11/29/2007WO2007135547A2 Selective estrogen receptor modulators or aromatase inhibitors for treating chronic nonbacterial prostatitis
11/29/2007WO2007135518A2 Use of choline-based preparations for the treatment of tinnitus
11/29/2007WO2007135505A2 Veterinary pharmaceutical compositions for the treatment of pain and inflammation
11/29/2007WO2007135466A2 Substituted n-acyl homoserine lactones
11/29/2007WO2007135463A1 Optical enantiomers of phenyramidol and process for chiral synthesis
11/29/2007WO2007135427A1 1,4-disubstituted piperazine and 1,4-disubstituted azepane as 11 -beta-hydroxysteroid dehydrogenase 1 inhibitors
11/29/2007WO2007135417A1 Benzotriazepinone derivatives
11/29/2007WO2007135411A1 39-desmethoxy-39-methyl derivatives of rapamycin.
11/29/2007WO2007135410A1 Ruthenium ii compounds
11/29/2007WO2007135409A1 Particulate drug and drug compositions and their uses
11/29/2007WO2007135408A1 Impurities of donepezil
11/29/2007WO2007135406A2 New forms of active pharmaceutical ingredient
11/29/2007WO2007135398A1 Indole derivatives
11/29/2007WO2007135397A1 36 -des (3 -methoxy-4 -hydroxycyclohexyl) 36 - (3 -hydroxycycloheptyl) derivatives of rapamycin for the treatment of cancer and other disorders
11/29/2007WO2007135390A1 Prevention of plaque formation
11/29/2007WO2007135387A1 Inhibitor of adenylyl cyclase for treating a disorder of the circadian rhythm
11/29/2007WO2007135380A2 Antiparasitic compounds and compositions
11/29/2007WO2007135362A2 Stable aqueous suspension having palatable taste
11/29/2007WO2007135350A1 Benzotriazepinone derivatives
11/29/2007WO2007135295A2 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same
11/29/2007WO2007135294A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
11/29/2007WO2007135293A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
11/29/2007WO2007135242A1 Composition for foodstuff for binding acetaldehyde
11/29/2007WO2007135210A1 Formulation of natural triterpenes and biophenols obtained from the genus olea in liposomes
11/29/2007WO2007135195A1 Ectonucleotidase inhibitors
11/29/2007WO2007135193A2 Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means
11/29/2007WO2007135172A2 Cladribine regimen for treating multiple sclerosis
11/29/2007WO2007135163A1 Use of poly(hexamethylene biguanide)hydrochloride as an antiviral agent
11/29/2007WO2007135141A1 Maternal supplement
11/29/2007WO2007135134A1 Crystalline a and b forms of a maleate salt of 5-amino-3- (2 ', 3 '-di-o-acetyl-beta-d-ribofuranosyl) -3h-thiaz0l0 [4, 5-d] pyrimidin-2-one
11/29/2007WO2007135132A1 Use of a composition consisting of a combination of hydroquinone, fluocinolone acetonide and tretinoin, intended for treatment signs of photoaging of the skin
11/29/2007WO2007135131A1 Substituted pyrazinone derivatives for use as a medicine
11/29/2007WO2007135122A1 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use
11/29/2007WO2007135121A1 Novel 8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use
11/29/2007WO2007135120A1 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use
11/29/2007WO2007135111A1 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament
11/29/2007WO2007135106A1 Piperidine derivatives as human papilloma virus inhibitors
11/29/2007WO2007135105A1 Means and method for inducing exon-skipping
1 ... 3478 3479 3480 3481 3482 3483 3484 3485 3486 3487 3488 3489 3490 3491 3492 3493 3494 3495 3496 3497 3498 ... 7860